K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma

Cancer

Volumn 82, Issue 1, 1998, Pages 96-103

  Wilentz, Robb E ^a,b   Chung, Christine H ^b   Sturm, Patrick D J ^b   Musler, Alex ^b   Sohn, Taylor A ^a   Offerhaus, G Johan A ^b   Yeo, Charles J ^a   Hruban, Ralph H ^a,c   Slebos, Robbert J C ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Duodenal fluid; K ras mutations; Pancreatic carcinoma; Whipple's operation

Indexed keywords

RAS PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SCREENING; CODON; CONTROLLED STUDY; DUODENUM FLUID; EARLY DIAGNOSIS; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PANCREAS CARCINOMA; PANCREATICODUODENECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; AMPULLA OF VATER; CARCINOMA; CHRONIC DISEASE; CODON; COMMON BILE DUCT NEOPLASMS; DNA PROBES; DNA, NEOPLASM; DUODENUM; FEMALE; GENES, RAS; HUMANS; INTESTINAL SECRETIONS; MALE; MIDDLE AGED; MUTATION; NUCLEIC ACID HYBRIDIZATION; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PANCREATITIS; POINT MUTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0031893736     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980101)82:1<96::AID-CNCR11>3.0.CO;2-8     Document Type: Article

References (41)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-27.
2. Warshaw AL, Castillo CF. Pancreatic carcinoma. N Engl J Med 1992;326:455-65.
3. DiGiuseppe JA, Yeo CJ, Hruban RH. Molecular biology and the diagnosis and treatment of adenocarcinoma of the pancreas. Adv Anat Path 1996;3:139.
4. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-31.
5. Barbacid M. Ras genes. Annu Rev Biochem 1987;56:779-827.
6. Almoguera C, Shibata D, Forrester K, Martin J, Arnehim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-54.
7. Smit VT, Boot AJ, Smits AM, Fleuren GJ, Cornelisse CJ, Bos JL. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 1988;16:7773-82.
8. Hruban RH, van Mansfield ADM, Offerhaus GJA, van Weering DH, Allison DC, Goodman SN, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-54.
9. Grünewald K, Lyons J, Frohlich A, Feichtinger H, Weger RA, Schwab G, et al. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989;43:1037-41.
10. Nagata Y, Abe M, Motoshima K, Nakayama E, Shiku H. Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese patients. Jpn J Cancer Res 1990;81:135-40.
11. Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK, et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;53:2472-4.
12. Watanabe H, Sawabu N, Ohta H, Satomura Y, Yamakawa O, Motoo Y, et al. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with pancreatic adenocarcinoma and pancreatic cancers. Jpn J Cancer Res 1993;84:961-5.
13. Watanabe H, Sawabu N, Songür Y, Yamaguchi Y, Yamakawa O, Satomura Y, et al. Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis. Pancreas 1996;12:18-24.
14. Miki H, Matsumoto S, Harada H, Mori S, Haba R, Ochi K, et al. Detection of c-Ki-ras point mutations from pancreatic juice. Int J Pancreatol 1993;14:145-8.
15. Kondo H, Sugano K, Fukayama N, Kyogoku A, Nose H, Shimada K, et al. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer 1994;73:1589-94.
16. Iguchi H, Sugano K, Fukayama N, Ohkura H, Sadamoto K, Ohkoshi K, et al. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterol 1996;110:221-6.
17. Shibata D, Almoguera C, Forrester K, Dunitz J, Martin SE, Cosgrove MM, et al. Detection of c-Ki-ras gene codon 12 mutations in fine needle aspirates from human pancreatic adenocarcinomas. Cancer Res 1990;50:1279-83.
18. van Laethem J-L, Vertongen P, Deviere J, van Rampelbergh J, Rickaert F, Cremer M, et al. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumors. Gut 1995;36:781-7.
19. van Es JM, Polak MM, van den Berg FM, Ramsoekh TB, Craanen ME, Hruban RH, et al. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product. J Clin Pathol 1995;48:218-22.
20. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994;54:3568-73.
21. Cubilla A, Fitzgerald PJ. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976;36:2690-8.
22. DiGiuseppe JA, Hruban RH, Offerhaus GJA, Clement MJ, van den Berg FM, Cameron JL, et al. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994;144:889-95.
23. Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano H, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-6.
24. Lemoine NR, Jain S, Hughes CM, Staddon SL, Maillet B, Hall PA, et al. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterol 1992;102:230-6.
25. Kozuka S, Sassa R, Taki T, Masamoto K, Nagasawa S, Saga S, et al. Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979;43:1418-28.
26. Shimuzu M, Itoh H, Okumura S, Hashimoto K, Hanioka K, Ohyanagi H, et al. Papillary hyperplasia of the pancreas. Hum Pathol 1989;20:806-7.
27. Obara T, Saitoh Y, Maguchi H, Ura H, Kitazawa S, Koike Y, et al. Multicentric development of pancreatic intraductal carcinoma through atypical papillary hyperplasia. Hum Pathol 1992;23:82-5.
28. Tabata T, Fujimori T, Maeda S, Yamamoto M, Saitoh Y. The role of ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int J Pancreatol 1993;14:237-44.
29. Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T. Analysis of K-ras gene mutations in hyperplastic duct cells of the pancreas without pancreas disease. Gastroenterology 1996;110:227-31.
30. Klimstra DS, Longnecker DL. K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol 1994;145:1547-50.
31. Hruban RH, Westra WH, Phelps TH, Isaacson C. Surgical pathology dissection: an illustrated guide. New York: Springer, 1996:72.
32. Sidransky D, Tokino D, Hamilton SR, Kinzler KW, Levin B, Frost P, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992;256:102-5.
33. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde-fixed and paraffin-embedded human tissue. Biochem Biophys Res Commun 1985;130:118-26.
34. Chung CH, Wilentz RE, Polak MM, Ramsoekh TB, Noorduyn LA, Gouma DJ, et al. Clinical significance of K-ras oncogene activation in ampullary neoplasms. J Clin Pathol 1996; 49:460-4.
35. Slebos RJC, Boerrigter L, Evers SG, Wisman P, Mooi WJ, Rodenhuis S. A rapid and simple procedure for the detection of ras mutations in formalin-fixed, paraffin-embedded tissue. Diagn Mol Pathol 1992;1:136-41.
36. Hruban RH, Sturm PDJ, Slebos RJC, Wilentz RE, Musler AR, Yeo CJ, et al. Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients. Am J Pathol 1997;151:943-9.
37. Motojima K, Urano T, Nagata Y, Shiku H, Tsurifune T, Kanematsu T. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg 1993;217:138-43.
38. Schaeffer BBK, Glasner S, Kuhlmann E, Myles JL, Longnecker DS. Mutated c-K-ras in small pancreatic adenocarcinomas. Pancreas 1994;9:161-5.
39. Berthelemy P, Bouisson M, Escourror J, Vaysse N, Rumeau JL, Pradayrol L. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 1995;123:188-91.
40. Tada M, Omata M, Ohto M. Ras gene mutations in intraductal papillary neoplasms of the pancreas: analysis in five cases. Cancer 1991;67:634-7.
41. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.